9926
COM:AKESOBIO
Akeso, Inc
- Stock
Last Close
73.25
22/11 08:08
Market Cap
33.06B
Beta: -
Volume Today
7.82M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 16.25M - | 38.38M 136.24% | 128.93M 235.93% | 269.23M 108.82% | 366.85M 36.26% | ||
average payables | 45.14M - | 77.77M 72.29% | 159.46M 105.05% | 257.63M 61.56% | 331.89M 28.82% | ||
average receivables | 283.30M - | ||||||
book value per share | 0.58 - | -0.01 101.44% | 5.06 60,940.82% | 3.88 23.44% | 3.19 17.62% | 5.60 75.24% | |
capex per share | -0.10 - | -0.31 218.19% | -0.71 130.63% | -0.88 23.08% | -0.97 10.83% | ||
capex to depreciation | -5.72 - | -14.31 150.25% | -20.29 41.79% | -12.30 39.39% | -7.59 38.30% | ||
capex to operating cash flow | 0.60 - | 1.07 78.83% | 0.73 32.44% | 0.72 1.48% | 0.65 9.54% | ||
capex to revenue | -26.24 - | -3.33 87.31% | -3.17 - | -0.96 69.82% | |||
cash per share | 0.54 - | 1.56 186.79% | 4.44 185.70% | 3.24 27.13% | 2.77 14.33% | 2.86 3.01% | |
days of inventory on hand | 2.30K - | 1.33K 42.26% | 1.07K 19.03% | ||||
days payables outstanding | 2.41K - | 1.20K 50.27% | 971.96 18.88% | ||||
days sales outstanding | 23.83 - | ||||||
debt to assets | 0.10 - | 0.09 8.93% | 0.05 43.23% | 0.18 246.55% | 0.34 91.19% | 0.32 5.18% | |
debt to equity | 0.15 - | -23.93 16,334.76% | 0.06 100.26% | 0.27 334.82% | 0.71 162.49% | 0.63 11.03% | |
dividend yield | 0.03 - | ||||||
earnings yield | -0.01 - | -0.02 137.79% | -0.06 185.33% | -0.05 19.18% | -0.04 22.72% | 0.06 256.61% | |
enterprise value | 15.90B - | 15.51B 2.47% | 17.65B 13.84% | 20.86B 18.17% | 31.43B 50.66% | 36.67B 16.69% | |
enterprise value over ebitda | -112.76 - | -47.82 57.59% | -13.68 71.40% | -17.41 27.28% | -24.58 41.16% | 19.73 180.28% | |
ev to operating cash flow | -128.82 - | -70.61 45.19% | -28.57 59.53% | -20.83 27.09% | -25.33 21.61% | 14.86 158.66% | |
ev to sales | 5.63K - | 218.77 96.11% | 92.45 - | 37.52 59.42% | 8.10 78.40% | ||
free cash flow per share | -0.26 - | -0.60 130.57% | -1.70 184.00% | -2.10 24.15% | -2.48 17.65% | 2.94 218.90% | |
free cash flow yield | -0.01 - | -0.03 125.10% | -0.05 92.24% | -0.08 43.26% | -0.06 14.87% | 0.07 208.46% | |
graham net net | 0.34 - | -0.34 201.53% | 3.85 1,217.65% | 1.49 61.31% | -0.59 139.80% | -2.21 272.59% | |
graham number | 1.55 - | 0.29 81.27% | 14.65 4,964.12% | 10.73 26.77% | 10.07 6.19% | 17.46 73.46% | |
income quality | 0.80 - | 0.63 20.73% | 0.47 26.19% | 0.80 70.12% | 0.87 9.59% | 1.22 39.50% | |
intangibles to total assets | 0.07 - | 0.09 20.16% | 0.04 56.39% | 0.03 19.90% | 0.03 4.21% | 0.00 97.61% | |
interest coverage | -58.19 - | -59.40 2.09% | -164.34 176.67% | -121.36 26.15% | -31.98 73.65% | ||
interest debt per share | 0.09 - | 0.21 133.10% | 0.33 59.16% | 1.07 223.92% | 2.33 118.60% | 3.55 52.40% | |
inventory turnover | 0.16 - | 0.28 73.18% | 0.34 23.50% | ||||
invested capital | 0.15 - | -23.93 16,334.76% | 0.06 100.26% | 0.27 334.82% | 0.71 162.49% | 0.63 11.03% | |
market cap | 16.15B - | 16.54B 2.43% | 20.14B 21.75% | 22.64B 12.43% | 31.64B 39.74% | 35.24B 11.37% | |
net current asset value | 293.89M - | -201.27M 168.48% | 2.60B 1,389.61% | 1.63B 37.33% | 110.54M 93.20% | 1.01B 817.75% | |
net debt to ebitda | 1.76 - | 3.19 80.82% | 1.93 39.61% | 1.49 22.76% | 0.17 88.79% | 0.77 362.55% | |
net income per share | -0.18 - | -0.45 143.57% | -1.88 321.51% | -1.32 29.96% | -1.41 6.81% | 2.42 271.69% | |
operating cash flow per share | -0.16 - | -0.29 77.93% | -0.98 241.35% | -1.23 24.93% | -1.50 22.53% | 2.94 295.83% | |
payables turnover | 0.15 - | 0.30 101.07% | 0.38 23.27% | ||||
receivables turnover | 15.31 - | ||||||
research and ddevelopement to revenue | 57.00 - | 4.35 92.37% | 4.98 - | 1.58 68.26% | 0.28 82.46% | ||
return on tangible assets | -0.23 - | -0.22 3.59% | -0.32 43.01% | -0.23 27.66% | -0.22 5.69% | 0.22 201.44% | |
revenue per share | 0.00 - | 0.09 2,408.10% | 0.28 - | 1.02 267.18% | 5.40 431.87% | ||
roe | -0.32 - | 53.69 17,015.69% | -0.37 100.69% | -0.34 8.52% | -0.44 29.65% | 0.43 197.97% | |
roic | -0.27 - | -2.19 704.57% | -0.35 84.15% | -0.27 23.26% | -0.25 6.19% | 0.23 192.13% | |
sales general and administrative to revenue | 2.39 - | 0.44 81.61% | 1.08 - | 0.24 77.99% | 0.04 81.39% | ||
shareholders equity per share | 0.58 - | -0.01 101.44% | 5.06 60,940.82% | 3.88 23.44% | 3.19 17.62% | 5.60 75.24% | |
stock based compensation to revenue | 0.80 - | 0.06 92.76% | |||||
tangible asset value | 440.79M - | 69.79M 84.17% | 3.30B 4,633.81% | 3.13B 5.14% | 2.39B 23.81% | 4.51B 88.99% | |
tangible book value per share | 0.58 - | 0.09 84.17% | 5.25 5,643.82% | 3.84 26.88% | 2.89 24.65% | 5.38 86.02% | |
working capital | 371.28M - | 1.14B 206.02% | 2.83B 149.19% | 2.50B 11.82% | 1.70B 32.01% | 4.47B 163.48% |
All numbers in (except ratios and percentages)